Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
BeWhere Holdings Inc. Announces Closing of its C$5.0 Million Brokered LIFE Offering, Including Full Exercise of Over-Allotment Option
-
Canaccord Genuity Starts Kiniksa (KNSA) at Buy
-
Canaccord Genuity Upgrades Sandfire Resources NL (SFR:AU) (SRAFF) to Buy
-
Canaccord Genuity Starts Chalice Mining Ltd (CHN:AU) at Spec. Buy
-
Canaccord Genuity Starts F3 Uranium Corp (FUU:CN) at Spec. Buy
-
Insulet Corporation (PODD) PT Lowered to $435 at Canaccord Genuity
-
Shoulder Innovations to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference
-
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
-
Marimaca Copper Completes Bookbuild for C$409 Million (~ A$423 Million)
-
Ultragenyx Pharma (RARE) PT Lowered to $79 at Canaccord Genuity
-
Kenvue Inc (KVUE) PT Raised to $18 at Canaccord Genuity
-
Holley (HLLY) PT Raised to $8 at Canaccord Genuity
-
AtriCure Inc. (ATRC) PT Lowered to $53 at Canaccord Genuity
-
AuMEGA Metals Announces Amended and Upsized Financing of C$30 Million, Anchored by Condire Investors, LLC
-
Form 8.3 - [IDOX PLC - 17 02 2026] - (CGWL)
-
Intention to transition to the Main Market of the London Stock Exchange and Voluntary Delisting from the TSX Venture Exchange
-
Marimaca Copper Announces Global Offering of C$409 Million (~ A$423 Million)
-
Maple Gold Announces Closing of Oversubscribed Concurrent Offerings for Gross Proceeds of $16 Million
-
Director/PDMR Shareholding
-
Net Asset Value(s)
-
Arcuro Medical Significantly Expands SuperBall® Market Opportunity with New Rotator Cuff Repair System; Launches Newly-Enhanced Meniscus Repair System
-
Canaccord Genuity Starts BitGo Holdings (BTGO) at Buy
-
Canaccord Genuity Starts Dexterra Group Inc. (DXT:CN) (HZNOF) at Buy
-
Form 8.3 - [IDOX PLC - 16 02 2026] - (CGWL)
-
Canaccord Genuity Downgrades Australian Clinical Labs Ltd (ACL:AU) to Hold
-
Empire Metals Limited Announces Major Drilling Campaign to Commence at Pitfield
-
Form 8.3 - [IDOX PLC - 13 02 2026] - (CGWL)
-
Canaccord Genuity Downgrades Peel Mining (PEX:AU) to Hold
-
10X Genomics (TXG) PT Raised to $22 at Canaccord Genuity
-
Rollins (ROL) PT Lowered to $52 at Canaccord Genuity
-
Artivion Inc. (AORT) PT Lowered to $48 at Canaccord Genuity
-
CVRx Inc (CVRX) PT Lowered to $10 at Canaccord Genuity
-
DexCom (DXCM) PT Lowered to $95 at Canaccord Genuity
-
Director/PDMR Shareholding
-
Allotment of Shares under DRIS
-
Issue of Equity
-
Evergold Appoints Dylan Berg as Capital Markets Advisor
-
Form 8.3 - [IDOX PLC - 12 02 2026] - (CGWL)
-
Vesting and New Awards under the Restricted Share Unit Plan (the “RSU Plan”) and Total Voting Rights
-
Commerce.com (CMRC) PT Lowered to $6 at Canaccord Genuity
-
XXIX Announces Closing of $17.3 Million Financing
-
Contango Ore completes $50 million stock and warrant offering
-
Contango Ore Closes $50 Million Underwritten Offering of Common Stock and Pre-funded Warrants
-
Canaccord Genuity Starts Applied Nutrition Plc (APN:LN) at Buy
-
Compass Gold Closes Private Placement of Units for Gross Proceeds of $5,398,330
-
Diversified Royalty Corp. Announces Closing of the Over-Allotment Option Exercised in Connection with its Recently Completed $60 Million Bought Deal Offering of 5.75% Convertible Unsecured Subordinate
-
Canaccord Genuity Reiterates Buy Rating on Neurocrine Bio. (NBIX)
-
SharkNinja (SN) PT Raised to $160 at Canaccord Genuity
-
Bahia Metals Corp. Completes Initial Public Offering of $5,750,000, with Full Exercise of Over-Allotment Option
-
Form 8.3 - [IDOX PLC - 11 02 2026] - (CGWL)

